- Home
- ABOS vs OPRX Comparison
ABOS vs OPRX Comparison
Compare ABOS & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABOS | OPRX |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.6M | 170.7M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ABOS | OPRX |
|---|---|---|
| Price | $0.22 | $8.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $1.00 | ★ $12.60 |
| AVG Volume (30 Days) | ★ 4.9M | 116.0K |
| Earning Date | 10-26-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $0.20 | $4.54 |
| 52 Week High | $3.60 | $16.84 |
Technical Indicators
Market Signals| Indicator | ABOS | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 20.55 | 47.24 |
| Support Level | N/A | $7.96 |
| Resistance Level | $2.66 | $9.29 |
| Average True Range (ATR) | 0.16 | 0.48 |
| MACD | -0.18 | -0.07 |
| Stochastic Oscillator | 1.06 | 16.05 |
Price Performance
Historical ComparisonAbout ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.